Drug GMP Report
July 2012
FDA Flags API Contamination Concerns in FMC 483
Industrial chemical giant FMC received a Form 483 after FDA investigators found the company failed to minimize contamination risks at an alkali plant in Green River, Wyo., that makes pharmaceutical grade sodium bicarbonate and other active pharmaceutical ingredients (API).
This article is viewable by subscribers only. To view this article, please select an option below.
|